Alcon (ALC) vs National Vision (EYE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Alcon (ALC) has outperformed National Vision (EYE) over the past year, losing 16.4% versus a loss of 39.5%. Over five years, ALC leads with a -19.3% price change compared with -73.5% for EYE. Alcon is the larger company by market cap ($30.45 billion vs $1.33 billion), about 22.9 times the size.
On valuation, National Vision trades at a lower forward P/E (13.9x vs 15.9x for Alcon). Alcon pays a dividend yielding 0.56%, while National Vision does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALC | EYE |
|---|---|---|
| Share price | $63.00 | $16.82 |
| Market cap | $30.45B | $1.33B |
| 1-day change | -0.30% | +0.48% |
| YTD return | -20.06% | -34.86% |
| 1-year return | -16.41% | -39.50% |
| 5-year return | -19.25% | -73.52% |
| P/E ratio (TTM) | 47.73 | 27.13 |
| Forward P/E | 15.89 | 13.92 |
| EPS (TTM) | $1.32 | $0.62 |
| Dividend yield | 0.56% | 0.00% |
| Annual dividend | $0.353 | $0.00 |
| Revenue (latest FY) | $10.40B | — |
| Revenue growth (YoY) | +4.94% | — |
| Net income (latest FY) | $980.00M | — |
| Gross margin | 55.24% | — |
| Operating margin | 13.08% | — |
| Net margin | 9.42% | — |
| 52-week high | $87.64 | $30.02 |
| 52-week low | $61.84 | $14.75 |
| Distance from 52-week high | -28.12% | -43.97% |
| Analyst consensus | buy | — |
| Avg. price target upside | +32.62% | — |
| Average volume | 1.86M | 2.14M |
| Shares outstanding | 483.40M | 79.07M |
| Employees | 25,000 | — |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alcon is about 22.9 times larger than National Vision by market value ($30.45B vs $1.33B).
- ALC has outperformed EYE by 23.1 percentage points over the past year.
- Alcon trades at a higher earnings multiple (47.7x vs 27.1x trailing P/E).
About Alcon
ALC stock →Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.
Health Care · Ophthalmic Goods · 25,000 employees
ALC vs EYE FAQ
Which is bigger, Alcon or National Vision?
Alcon (ALC) is larger, with a market capitalization of $30.45B compared with $1.33B for National Vision (EYE).
Which stock has performed better over the past year, ALC or EYE?
ALC returned -16.41% over the past 12 months, compared with -39.50% for EYE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ALC or EYE?
EYE has the lower trailing P/E at 27.1, versus 47.7 for ALC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Alcon or National Vision?
Alcon pays a dividend yielding 0.56%, while National Vision does not currently pay a regular dividend.
Are Alcon and National Vision in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.